Elaborating, the NPPA said the hospital charged Rs 287.50 for Dotamin 200 mg whose procurement price per unit stood at Rs 28.35, a margin of 914 per cent.
Fortis also charged Rs 3,112.50 for Merocrit 1 GM thus charging a margin of 670 per cent. The hospital had procured the formulation at Rs 404.32 per unit, the regulator said.
Regarding the scheduled formulations which are under the ambit of price control, the NPPA said the hospital charged up to 343 per cent from the family of Adya.
The per unit procurement price of Tranemic by the hospital stood at Rs 15.75 while it was billed at Rs 69.77 per unit to the family.
The regulator gave a list of 39 scheduled formulations, 41 non-scheduled formulations and 96 consumables that were used for the treatment of Adya.
"NPPA shall be taking necessary follow up the action as per existing law and within its jurisdiction," the regulator said.
The reply of Fortis Healthcare could not be obtained at the time of filing the story.
The drug authority's action came after the Union health ministry asked all states to issue strict warnings and take action against hospitals, including private ones, which indulge in malpractices such as overcharging and do not follow standard treatment protocols.